690 related items for PubMed ID: 17961741
1. Biochemical remission and recurrence rate of secreting pituitary adenomas after transsphenoidal adenomectomy: long-term endocrinologic follow-up results.
Santoro A, Minniti G, Ruggeri A, Esposito V, Jaffrain-Rea ML, Delfini R.
Surg Neurol; 2007 Nov; 68(5):513-8; discussion 518. PubMed ID: 17961741
[Abstract] [Full Text] [Related]
2. Transsphenoidal adenomectomy for GH-, PRL- and ACTH-secreting pituitary tumours: outcome analysis in a series of 125 patients.
Esposito V, Santoro A, Minniti G, Salvati M, Innocenzi G, Lanzetta G, Cantore G.
Neurol Sci; 2004 Dec; 25(5):251-6. PubMed ID: 15624082
[Abstract] [Full Text] [Related]
3. Endocrinological outcome following first time transsphenoidal surgery for GH-, ACTH-, and PRL-secreting pituitary adenomas.
Kristof RA, Schramm J, Redel L, Neuloh G, Wichers M, Klingmüller D.
Acta Neurochir (Wien); 2002 Jun; 144(6):555-61; discussion 561. PubMed ID: 12111488
[Abstract] [Full Text] [Related]
4. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
Yamada S, Fukuhara N, Horiguchi K, Yamaguchi-Okada M, Nishioka H, Takeshita A, Takeuchi Y, Ito J, Inoshita N.
J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
[Abstract] [Full Text] [Related]
5. Pure endoscopic endonasal approach for pituitary adenomas: early surgical results in 200 patients and comparison with previous microsurgical series.
Dehdashti AR, Ganna A, Karabatsou K, Gentili F.
Neurosurgery; 2008 May; 62(5):1006-15; discussion 1015-7. PubMed ID: 18580798
[Abstract] [Full Text] [Related]
6. Outcome of transsphenoidal surgery for Cushing's disease: a high remission rate in ACTH-secreting macroadenomas.
Fomekong E, Maiter D, Grandin C, Raftopoulos C.
Clin Neurol Neurosurg; 2009 Jun; 111(5):442-9. PubMed ID: 19200645
[Abstract] [Full Text] [Related]
7. Fully endoscopic transsphenoidal surgery for functioning pituitary adenomas: a retrospective comparison with traditional transsphenoidal microsurgery in the same institution.
D'Haens J, Van Rompaey K, Stadnik T, Haentjens P, Poppe K, Velkeniers B.
Surg Neurol; 2009 Oct; 72(4):336-40. PubMed ID: 19604551
[Abstract] [Full Text] [Related]
8. Endoscopic transsphenoidal treatment in recurrent and residual pituitary adenomas--first experience.
Rudnik A, Zawadzki T, Gałuszka-Ignasiak B, Bazowski P, Duda I, Wojtacha M, Rudnik AI, Krawczyk I.
Minim Invasive Neurosurg; 2006 Feb; 49(1):10-4. PubMed ID: 16547875
[Abstract] [Full Text] [Related]
9. [Transsphenoidal resection of pituitary adenomas: long-term results from the Leiden University Medical Center].
Biermasz NR, Dekkers OM, Voormolen J, de Keizer RJ, Neelis KJ, Wiggers-de Bruïne FT, Smit JW, Arias AM, Romijn JA.
Ned Tijdschr Geneeskd; 2008 Nov 22; 152(47):2565-70. PubMed ID: 19174939
[Abstract] [Full Text] [Related]
10. Long-term follow-up of patients with pituitary macroadenomas after postoperative radiation therapy: analysis of tumor control and functional outcome.
Langsenlehner T, Stiegler C, Quehenberger F, Feigl GC, Jakse G, Mokry M, Langsenlehner U, Kapp KS, Mayer R.
Strahlenther Onkol; 2007 May 22; 183(5):241-7. PubMed ID: 17497095
[Abstract] [Full Text] [Related]
11. Fractionated stereotactic conformal radiotherapy for secreting and nonsecreting pituitary adenomas.
Minniti G, Traish D, Ashley S, Gonsalves A, Brada M.
Clin Endocrinol (Oxf); 2006 May 22; 64(5):542-8. PubMed ID: 16649974
[Abstract] [Full Text] [Related]
12. Pituitary tumor type affects the chance of biochemical remission after radiosurgery of hormone-secreting pituitary adenomas.
Pollock BE, Brown PD, Nippoldt TB, Young WF.
Neurosurgery; 2008 Jun 22; 62(6):1271-6; discussion 1276-8. PubMed ID: 18824993
[Abstract] [Full Text] [Related]
13. Current state of the art in the diagnosis and surgical treatment of Cushing disease: early experience with a purely endoscopic endonasal technique.
Dehdashti AR, Gentili F.
Neurosurg Focus; 2007 Jun 22; 23(3):E9. PubMed ID: 17961027
[Abstract] [Full Text] [Related]
14. Endoscopic endonasal transsphenoidal surgery for functional pituitary adenomas.
Hofstetter CP, Shin BJ, Mubita L, Huang C, Anand VK, Boockvar JA, Schwartz TH.
Neurosurg Focus; 2011 Apr 22; 30(4):E10. PubMed ID: 21456921
[Abstract] [Full Text] [Related]
15. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
Mukherjee A, Murray RD, Teasdale GM, Shalet SM.
Clin Endocrinol (Oxf); 2004 Apr 22; 60(4):476-83. PubMed ID: 15049963
[Abstract] [Full Text] [Related]
16. Fully endoscopic endonasal vs. transseptal transsphenoidal pituitary surgery.
Kabil MS, Eby JB, Shahinian HK.
Minim Invasive Neurosurg; 2005 Dec 22; 48(6):348-54. PubMed ID: 16432784
[Abstract] [Full Text] [Related]
17. Surgical and endocrinological outcomes in the treatment of growth hormone-secreting pituitary adenomas according to the shift of surgical paradigm.
Ku CR, Kim EH, Oh MC, Lee EJ, Kim SH.
Neurosurgery; 2012 Dec 22; 71(2 Suppl Operative):ons192-203; discussion ons203. PubMed ID: 22743357
[Abstract] [Full Text] [Related]
18. The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery.
Meij BP, Lopes MB, Ellegala DB, Alden TD, Laws ER.
J Neurosurg; 2002 Feb 22; 96(2):195-208. PubMed ID: 11838791
[Abstract] [Full Text] [Related]
19. The long-term efficacy of conventional radiotherapy in patients with GH-secreting pituitary adenomas.
Minniti G, Jaffrain-Rea ML, Osti M, Esposito V, Santoro A, Solda F, Gargiulo P, Tamburrano G, Enrici RM.
Clin Endocrinol (Oxf); 2005 Feb 22; 62(2):210-6. PubMed ID: 15670198
[Abstract] [Full Text] [Related]
20. Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria.
Kreutzer J, Vance ML, Lopes MB, Laws ER.
J Clin Endocrinol Metab; 2001 Sep 22; 86(9):4072-7. PubMed ID: 11549628
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
